Subserosal Layer and/or Pancreatic Invasion Based on Anatomical Features as a Novel Prognostic Indicator in Patients with Distal Cholangiocarcinoma
-
Published:2023-11-09
Issue:22
Volume:13
Page:3406
-
ISSN:2075-4418
-
Container-title:Diagnostics
-
language:en
-
Short-container-title:Diagnostics
Author:
Yoshii Hisamichi1ORCID, Izumi Hideki1, Fujino Rika1, Kurata Makiko2, Inomoto Chie2, Sugiyama Tomoko2, Nakagohri Toshio3, Nomura Eiji1, Mukai Masaya1, Tajiri Takuma2
Affiliation:
1. Department of Gastroenterological Surgery, Tokai University Hachioji Hospital, Tokyo 192-0032, Japan 2. Department of Diagnostic Pathology, Tokai University Hachioji Hospital, Tokyo 192-0032, Japan 3. Department of Gastroenterological Surgery, Tokai University Hospital, Isehara 259-1193, Japan
Abstract
The American Joint Committee on Cancer (AJCC) 8th edition T-staging system for distal cholangiocarcinoma (DCC) proposes classification according to the depth of invasion (DOI); nevertheless, DOI measurement is complex and irreproducible. This study focused on the fibromuscular layer and evaluated whether the presence or absence of penetrating fibromuscular invasion of DCC contributes to recurrence and prognosis. In total, 55 patients pathologically diagnosed with DCC who underwent surgical resection from 2002 to 2022 were clinicopathologically examined. Subserosal layer and/or pancreatic (SS/Panc) invasion, defined as penetration of the fibromuscular layer and invasion of the subserosal layer or pancreas by the cancer, was assessed with other clinicopathological prognostic factors to investigate recurrence and prognostic factors. According to the AJCC 8th edition, there were 11 T1, 28 T2, and 16 T3 cases, with 44 (80%) cases of SS/Panc invasion. The DOI was not significantly different for both recurrence and prognostic factors. In the multivariate analysis, only SS/Panc was identified as an independent factor for prognosis (hazard ratio: 16.1; 95% confidence interval: 2.1–118.8, p = 0.006). In conclusion, while the determination of DOI in DCC does not accurately reflect recurrence and prognosis, the presence of SS/Panc invasion may contribute to the T-staging system.
Subject
Clinical Biochemistry
Reference34 articles.
1. Amin, M.B., Edge, S.B., Greene, F.L., and Byrd, D.R. (2016). AJCC Cancer Staging Manual, Springer. [8th ed.]. 2. Cholangiocarcinoma: Thirty-one-year experience with 564 patients at a single institution;DeOliveira;Ann. Surg.,2007 3. Cholangiocarcinoma: Are North American surgical outcomes optimal?;Loehrer;J. Am. Coll. Surg.,2013 4. Smooth muscle distribution in the extrahepatic bile duct: Histologic and immunohistochemical studies of 122 cases;Hong;Am. J. Surg. Pathol.,2000 5. Edge, S.B., Byrd, D.R., Compton, C.C., Fritz, A.G., Greene, F.L., and Trotti, A. (2010). AJCC Cancer Staging Manual, Springer. [7th ed.].
|
|